230 related articles for article (PubMed ID: 20853184)
1. Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.
Santoro L; Breedveld GJ; Manganelli F; Iodice R; Pisciotta C; Nolano M; Punzo F; Quarantelli M; Pappatà S; Di Fonzo A; Oostra BA; Bonifati V
Neurogenetics; 2011 Feb; 12(1):33-9. PubMed ID: 20853184
[TBL] [Abstract][Full Text] [Related]
2. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome.
Di Fonzo A; Dekker MC; Montagna P; Baruzzi A; Yonova EH; Correia Guedes L; Szczerbinska A; Zhao T; Dubbel-Hulsman LO; Wouters CH; de Graaff E; Oyen WJ; Simons EJ; Breedveld GJ; Oostra BA; Horstink MW; Bonifati V
Neurology; 2009 Jan; 72(3):240-5. PubMed ID: 19038853
[TBL] [Abstract][Full Text] [Related]
3. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.
Paisán-Ruiz C; Guevara R; Federoff M; Hanagasi H; Sina F; Elahi E; Schneider SA; Schwingenschuh P; Bajaj N; Emre M; Singleton AB; Hardy J; Bhatia KP; Brandner S; Lees AJ; Houlden H
Mov Disord; 2010 Sep; 25(12):1791-800. PubMed ID: 20669327
[TBL] [Abstract][Full Text] [Related]
4. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
[TBL] [Abstract][Full Text] [Related]
5. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
[TBL] [Abstract][Full Text] [Related]
6. A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism.
Yalcin-Cakmakli G; Olgiati S; Quadri M; Breedveld GJ; Cortelli P; Bonifati V; Elibol B
Parkinsonism Relat Disord; 2014 Nov; 20(11):1248-52. PubMed ID: 25085748
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
[TBL] [Abstract][Full Text] [Related]
8. Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene.
Radi E; Formichi P; Di Maio G; Battisti C; Federico A
J Cell Mol Med; 2012 Aug; 16(8):1916-23. PubMed ID: 22117566
[TBL] [Abstract][Full Text] [Related]
9. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
Park JS; Sue CM
Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.
Behrens MI; Brüggemann N; Chana P; Venegas P; Kägi M; Parrao T; Orellana P; Garrido C; Rojas CV; Hauke J; Hahnen E; González R; Seleme N; Fernández V; Schmidt A; Binkofski F; Kömpf D; Kubisch C; Hagenah J; Klein C; Ramirez A
Mov Disord; 2010 Sep; 25(12):1929-37. PubMed ID: 20683840
[TBL] [Abstract][Full Text] [Related]
11. ATP13A2 novel mutations causing a rare form of juvenile-onset Parkinson disease.
Suleiman J; Hamwi N; El-Hattab AW
Brain Dev; 2018 Oct; 40(9):824-826. PubMed ID: 29903538
[TBL] [Abstract][Full Text] [Related]
12. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.
Pietrzak A; Badura-Stronka M; Kangas-Kontio T; Felczak P; Kozubski W; Latos-Bielenska A; Wierzba-Bobrowicz T; Florczak-Wyspianska J
Folia Neuropathol; 2019; 57(3):285-294. PubMed ID: 31588715
[TBL] [Abstract][Full Text] [Related]
13. Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15).
Zhao T; De Graaff E; Breedveld GJ; Loda A; Severijnen LA; Wouters CH; Verheijen FW; Dekker MC; Montagna P; Willemsen R; Oostra BA; Bonifati V
PLoS One; 2011 Feb; 6(2):e16983. PubMed ID: 21347293
[TBL] [Abstract][Full Text] [Related]
14. Neuropathologic Findings in a Patient With Juvenile-Onset Levodopa-Responsive Parkinsonism Due to
Chien HF; Rodriguez RD; Bonifati V; Nitrini R; Pasqualucci CA; Gelpi E; Barbosa ER
Neurology; 2021 Oct; 97(16):763-766. PubMed ID: 34475127
[TBL] [Abstract][Full Text] [Related]
15. Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9).
Eiberg H; Hansen L; Korbo L; Nielsen IM; Svenstrup K; Bech S; Pinborg LH; Friberg L; Hjermind LE; Olsen OR; Nielsen JE
Clin Genet; 2012 Sep; 82(3):256-63. PubMed ID: 21696388
[TBL] [Abstract][Full Text] [Related]
16. Autosomal recessive parkinsonism.
Bonifati V
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S4-6. PubMed ID: 22166450
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.
Bras J; Verloes A; Schneider SA; Mole SE; Guerreiro RJ
Hum Mol Genet; 2012 Jun; 21(12):2646-50. PubMed ID: 22388936
[TBL] [Abstract][Full Text] [Related]
18. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.
Hansen FH; Skjørringe T; Yasmeen S; Arends NV; Sahai MA; Erreger K; Andreassen TF; Holy M; Hamilton PJ; Neergheen V; Karlsborg M; Newman AH; Pope S; Heales SJ; Friberg L; Law I; Pinborg LH; Sitte HH; Loland C; Shi L; Weinstein H; Galli A; Hjermind LE; Møller LB; Gether U
J Clin Invest; 2014 Jul; 124(7):3107-20. PubMed ID: 24911152
[TBL] [Abstract][Full Text] [Related]
19. FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family.
Gündüz A; Eken AG; Bilgiç B; Hanagasi HA; Bilgüvar K; Günel M; Başak AN; Ertan S
Parkinsonism Relat Disord; 2014 Nov; 20(11):1253-6. PubMed ID: 25169713
[TBL] [Abstract][Full Text] [Related]
20. Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.
Myhre R; Steinkjer S; Stormyr A; Nilsen GL; Abu Zayyad H; Horany K; Nusier MK; Klungland H
BMC Neurol; 2008 Dec; 8():47. PubMed ID: 19087301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
